PERRIGO PE ratio PRGO

Share price divided by earnings per share over the last twelve months, since 2014.

Today, Oct 23, 2026: n/m; losses over the last year
Last meaningful: 25.2×; Oct 2020
9-year median: 50.1×
9-year range: 25.2× to 101×
Peer median: 15.7×

PERRIGO has no meaningful PE ratio today: it lost $12.46 a share over the last twelve months, and a PE needs earnings.

It was last meaningful in Oct 2020, at 25.2×.

On the days it had one over the last 9 years, its median was 50.1×, from 25.2× in Oct 2020 to 101× in Mar 2018.

PE ratio over time

median 50.1×

The dashed line is the 9-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2020	25.2×	25.2×	49.7×
2019	28.7×	27.1×	86.1×
2018	46.4×	40.9×	101×
2017	n/m a value too high to mean anything
2016	131×	131×	150×
2015	146×	58.5×	209×
2014	139×	129×	141×

Against its peers

Companies in Drug Manufacturers - General nearest PERRIGO's size, closest first, today.

Company	PE ratio
PRGOPERRIGO	n/m
PBHPrestige Consumer Healthcare	13.4×
HRMYHarmony Biosciences	11.7×
NRIXNurix Therapeutics	11.0×
ANIPANI Pharmaceuticals	15.4×
PAHCPhibro Animal Health	15.9×
ANABAnaptysbio	10.7×
PCRXPacira BioSciences	104×
OGNOrganon	17.9×
LQDALiquidia	30.7×
ARQTArcutis Biotherapeutics	142×
Peer median	15.7×

What the PE ratio tells you

Share price divided by earnings per share over the last twelve months. It is the price tag on a dollar of profit: 20× means you pay $20 for $1 of yearly earnings.

Blank while earnings are negative. A very low PE can mean the market expects profits to fall, so read it with growth and the company's own history.

More on PERRIGO

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.